Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Immunodiagnostic Systems Hldgs PLC

24 May 2021 13:39

RNS Number : 6177Z
Immunodiagnostic Systems Hldgs PLC
24 May 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Immunodiagnostic Systems Holdings plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Immunodiagnostic Systems Holdings plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

21 May 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

0

NIL

0

(2) Cash-settled derivatives:

 

NIL

0

NIL

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

0

NIL

0

 

TOTAL:

NIL

0

NIL

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Interests of directors of Immunodiagnostic Systems Holdings plc in Immunodiagnostic Systems Holdings plc's ordinary shares of 2 pence each

 

Name

Number of ordinary shares of 2 pence each

Percentage of total issued share capital (%) (excluding treasury shares and any shares held under option)

Klaus Peter Kaspar

18,100

0.06

Paul James Martin

22,350

0.08

Jaap Stuut

7,500

0.03

Peter John Williamson

45,000

0.16

Burkhard Wittek*

8,259,759

28.70

 

*Dr Wittek's shares are held by Forum Venture Capital GmbH, Forum European Smallcaps GmbH, Forum Family Office Venture Fund and his spouse and children

 

b) Details of awards granted to the directors of Immunodiagnostic Systems Holdings plc over Immunodiagnostic Systems Holdings plc's ordinary shares of 2 pence each

Name

Number of ordinary shares of 2 pence each

Percentage of total issued share capital (%) (excluding any shares held under option)

Grant date

Vesting date

Exercise price (p)

Expiry date

Jaap Stuut

7,500

0.03

29/03/18

29/03/21

220

29/03/28

Jaap Stuut

7,500

0.03

28/03/19

06/12/21

190

28/03/29

Jaap Stuut

7,500

0.03

31/03/20

20/02/23

210

31/03/30

Jaap Stuut

7,500

0.03

17/05/21

29/03/24

195

17/05/31

Paul Martin

30,000

0.10

28/03/17

23/06/19

132

28/03/27

Paul Martin

9,000

0.03

28/03/17

28/03/20

277.5

28/03/27

Paul Martin

6,300

0.02

29/03/18

20/06/20

290

29/03/28

Paul Martin

2,283

0.01

29/03/18

29/03/21

220

29/03/28

Paul Martin

3,717

0.01

29/03/18

29/03/21

220

29/03/28

Paul Martin

6,750

0.02

28/03/19

06/12/21

184

28/03/29

Paul Martin

30,000

0.10

25/06/19

23/06/22

180

25/06/29

Paul Martin

9,000

0.03

31/03/20

21/02/23

220

31/03/30

Paul Martin

9,000

0.03

31/03/20

23/03/23

170

31/03/30

Paul Martin

6,300

0.02

17/05/21

20/06/23

275

17/05/31

Paul Martin

6,000

0.02

17/05/21

29/03/24

195

17/05/31

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

24 May 2021

Contact name:

Paul Martin

Telephone number:

+44 ( 0) 191 519 6111

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEAASLADXFEFA
Date   Source Headline
7th Oct 20092:24 pmRNSAllotment of shares
5th Oct 20097:00 amRNSNon Regulatory Announcement
5th Oct 20097:00 amRNSTrading Update
24th Sep 200910:06 amRNSNew specialist assay launched for IDS-iSYS
15th Sep 20092:36 pmRNSDirector/PDMR Shareholding
4th Sep 20097:00 amRNSLicensing agreement & Directorate Change
20th Aug 20097:00 amRNSHolding(s) in Company
31st Jul 20094:02 pmRNSAGM Statement
7th Jul 20093:00 pmRNSAnnual Report and Accounts
2nd Jul 20097:00 amRNSNew specialist assay launched for IDS-iSYS
29th Jun 200912:57 pmRNSDirectors' Dealings
23rd Jun 200912:02 pmRNSIssue of Share Options
22nd Jun 20097:00 amRNSFinal Results
29th May 20097:00 amRNSChange of adviser and Notice of results
30th Apr 20092:55 pmRNSTotal Voting Rights
21st Apr 20095:03 pmRNSAdditional Listing
2nd Apr 200911:53 amRNSDirector Declaration
25th Mar 20097:00 amRNSTrading Update
2nd Mar 20097:00 amRNSIDS iSYS Launch
28th Jan 20097:00 amRNSIDS iSYS Launch Update
22nd Jan 200911:58 amRNSHolding(s) in Company
2nd Jan 20097:00 amRNSDisposal
31st Dec 200811:09 amRNSTotal Voting Rights
23rd Dec 200812:13 pmRNSHolding(s) in Company
10th Dec 20083:26 pmRNSInterim Results
10th Dec 20083:25 pmRNSIssue of Equity
14th Nov 20087:01 amRNSDisposal Update
13th Oct 20087:00 amRNSTrading Statement
2nd Oct 200811:00 amRNSAppointment of Joint Broker
29th Aug 20084:38 pmRNSResult of AGM
29th Aug 20084:35 pmRNSTotal Voting Rights
12th Aug 20085:34 pmRNSAnnual Report and AGM Notice
6th Aug 200811:56 amRNSAdditional Listing
28th Jul 20082:48 pmRNSHolding(s) in Company
14th Jul 20087:00 amRNSFinal Results
9th Jun 20087:00 amRNSDetails of Site Visit
28th May 20087:00 amRNSIndustry Award Win
2nd May 20084:16 pmRNSDirector/PDMR Shareholding
18th Apr 20087:00 amRNSIssue of Share Options
10th Apr 200810:57 amRNSDirector/PDMR Shareholding
1st Apr 20087:01 amRNSTrading update & agreement
27th Feb 200812:05 pmRNSAdditional Listing
25th Feb 20087:01 amRNSCollaboration agreement
11th Feb 20084:01 pmRNSDirector/PDMR Shareholding
11th Jan 20087:01 amRNSNew Rat/Mouse PINP Assay
27th Dec 200710:02 amRNSIssue of Options
18th Dec 200710:05 amRNSHolding(s) in Company
10th Dec 20077:01 amRNSInterim Results
3rd Dec 20079:26 amRNSChange of Adviser
21st Nov 20079:14 amRNSNotifiable Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.